FDA Approved: BUDESONIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for budesonide submitted by Teva Pharmaceuticals USA, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Asthma
• Crohn Disease
• Rhinosinusitis with Nasal Polyps
• Ulcerative Colitis

Drugs mentioned

• Budesonide (BUDESONIDE)

Snippet

SUPPL AP for BUDESONIDE (BUDESONIDE)